ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Nicox SA

Nicox SA (ALCOX)

0.304
0.002
(0.66%)
Cerrado 09 Febrero 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.304
Postura de Compra
0.296
Postura de Venta
0.304
Volume Operado de la Acción
155,673
0.296 Rango del Día 0.31
0.14 Rango de 52 semanas 0.4915
Capitalización de Mercado [m]
Precio Anterior
0.302
Precio de Apertura
0.31
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
142,451
Acciones en circulación
50,299,694
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-13.66
Beneficio por acción (BPA)
-0.42
turnover
7.14M
Beneficio neto
-20.88M

Acerca de Nicox SA

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Antibes, Alpes-maritimes, Fra
Fundado
-
Nicox SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCOX. The last closing price for Nicox was 0.30 €. Over the last year, Nicox shares have traded in a share price range of 0.14 € to 0.4915 €.

Nicox currently has 50,299,694 shares in issue. The market capitalisation of Nicox is 15.19 € million. Nicox has a price to earnings ratio (PE ratio) of -13.66.

ALCOX Últimas noticias

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Press Release Nicox Announces Scientific Presentation and Conference Attendance in H1 2025January 28, 2025 – release at...

Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025

Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Communiqué de presseNicox : Présentation Scientifique et Participation aux Congrès du premier semestre...

Nicox confirme son éligibilité au PEA-PME

Nicox confirme son éligibilité au PEA-PME Communiqué de presseNicox confirme son éligibilité au PEA-PME22 janvier 2025 – publication à 7H30Sophia Antipolis, FranceNicox SA (Euronext Growth Paris :...

Nicox : Point d’activité et résumé financier du quatrième trimestre 2024

Nicox : Point d’activité et résumé financier du quatrième trimestre 2024 Communiqué de presseNicox : Point d’activité et résumé financier du quatrième trimestre 2024  Recrutement du dernier...

Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights

Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the...

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Communiqué de presseNicox annonce la première...

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Press Release Nicox Announces First Commercial Sale of ZERVIATE in China...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.003-0.9771986970680.3070.310.291573990.30014254DE
4-0.017-5.295950155760.3210.3260.2905804700.30470362DE
120.06426.66666666670.240.3350.20051424510.2855273DE
260.134679.45690672960.16940.3350.142457790.26233817DE
52-0.101-24.93827160490.4050.49150.141742510.26458174DE
156-0.278-47.76632302410.5820.650.141353840.31745213DE
260-0.278-47.76632302410.5820.650.141353840.31745213DE

ALCOX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Nicox?
El precio actual de las acciones de Nicox es 0.304 €
¿Cuántas acciones de Nicox están en circulación?
Nicox tiene 50,299,694 acciones en circulación
¿Cuál es la capitalización de mercado de Nicox?
La capitalización de mercado de Nicox es EUR 15.19M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Nicox?
Nicox ha negociado en un rango de 0.14 € a 0.4915 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Nicox?
El ratio precio/beneficio de Nicox es -13.66
¿Cuál es el ratio de efectivo a ventas de Nicox?
El ratio de efectivo a ventas de Nicox es 39.93
¿Cuál es la moneda de reporte de Nicox?
Nicox presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Nicox?
El último ingresos anual de Nicox es EUR 7.14M
¿Cuál es el último beneficio anual de Nicox?
El último beneficio anual de Nicox es EUR -20.88M
¿Cuál es la dirección registrada de Nicox?
La dirección registrada de Nicox es SUNDESK SOPHIA ANTIPOLIS ,EMERALD SQUARE, B��TIMENT C, RUE EVARISTE GALOIS, BIOT, ANTIBES, ALPES-MARITIMES, 06410
¿Cuál es la dirección del sitio web de Nicox?
La dirección del sitio web de Nicox es www.nicox.com
¿En qué sector industrial opera Nicox?
Nicox opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCABCabasse SA
0.77 €
(67.39%)
27.75k
ALEXPOne Experience
0.496 €
(64.24%)
2.54k
VTRVitura
5.80 €
(62.92%)
2.37k
DMSBSDiagnostic Medical Systems
0.007 €
(40.00%)
15.1k
ALVERVergnet
0.0009 €
(28.57%)
23.09M
ALCYBCybergun
0.0001 €
(-50.00%)
41.24k
BAIOdyssey Acquisition SA
0.1285 €
(-49.80%)
834.05k
ALALOAcheterLouerFR
0.0148 €
(-34.80%)
675.2k
MLWEYWeya
0.018 €
(-33.33%)
52.31k
MLCOTCoretech 5
0.0335 €
(-33.00%)
61k
ATOAtos SE
0.0021 €
(0.00%)
90.2M
ALVERVergnet
0.0009 €
(28.57%)
23.09M
BCPBanco Comercial Portugues SA
0.5008 €
(-1.14%)
10.34M
ALNRGEnergisme SA
0.0039 €
(5.41%)
10.05M
ALHGLouis Hachette Group
1.331 €
(-2.90%)
8.08M
Testpilot Testpilot 7 minutos hace
I see that sales only dropped by .46%, however the operating income, Net income from continuing operation before income tax, along with Net income fell by -22.99%, -88.36%, and -94.40% respectively. The company submitted a vague explanation "Recognizing subsidiary equity loss and impairment" as to
CRTG
nshi2 nshi2 8 minutos hace
https://youtu.be/2xE4bopeXhw
LWLG
thecrusher2011 thecrusher2011 9 minutos hace
😂😂😂😂 you're still mad that I noticed all liberals are feminine
Louinjaxxx Louinjaxxx 13 minutos hace
A friend of mine wrote a book on TA (Technical Analysis).  It was his opinion, and I agree with him, that TA and charting is worthless when dealing with penny stocks and especially with sub-penny stocks.
AXXA
LVerstee LVerstee 24 minutos hace
I’ll wait. You either missed it or chose not to acknowledge it. Your insults don’t affect me, and I won’t take any satisfaction when you eventually understand what I mean. Not with you.
You showed one half of the evidence and you can't even tell yourself.
All you’ve proven is that you
ITUP
DMC8 DMC8 25 minutos hace
https://www.sciencedirect.com/science/article/pii/S104366182500060X
AMRN
jeunke22 jeunke22 26 minutos hace
One would imagine these guys have business plans in place and are aware of the critical success factors. I guess Deep Seek was a wake up call to keep an eye on capex, costs , power and sustainability.
For me Lightwave’s value propositions are becoming more solid going forward. Enjoy the Super
LWLG
theswordman theswordman 27 minutos hace
What exactly was his contribution on those papers that had him listed as an author?

What exactly was his contribution on EVERY SEC filing that had him listed as CEO?

Absolutely nothing--say it again (What is IT good for?) Absolutely nothing

Leronlimab des
CYDY
janice shell janice shell 30 minutos hace
Impressive!

https://x.com/gunsnrosesgirl3/status/1888500878446887109
janice shell janice shell 35 minutos hace
Why do these kinds of people never seem to understand they look like incels playing dress-up?

They get home and Mom asks, "What?? You BURNED that outfit I spend two days making for you??"
janice shell janice shell 46 minutos hace
Oh yes, Two hundred years of brilliant Russian novels. Similar to our own tradition in its quality and duration, really, except that none of our authors were ever sent off to the Gulag. The military, yes, but not political prison camps. However, it's a bit late to enter on a discussion of comparativ
janice shell janice shell 53 minutos hace
Oh my! So the Man Camp guy also runs a megachurch in Ohio? Do we think he knows Paula? Perhaps he does Manly things with her?

But as far as Crusher is concerned, I just think it's SO exciting to have our very first BOLSHIE on the board!! Not a mere Pinko, a BOLSHEVIK!!
fliper fliper 1 hora hace
Fridays filing fwiw:
https://www.otcmarkets.com/filing/html?id=18167517&guid=mf0-kqyAqwruQOh
HADV
janice shell janice shell 1 hora hace
Nice, dear. And today a federal judge gave Musk and his DOGEbags the smackdown they've been asking for.

So one of those DOGEbags spent a good deal of time posting on the social media, "I was a white supremacist before it was cool!" and other repellent stuff. Musk chuckled and said boy
igotthemojo igotthemojo 1 hora hace
"As of December 31, 2023, there was $2,617,211 in loan interest"

nope...there was $1.6 mil in outstanding LOANS (not interest)...

"As of December 31, 2024, there was a preliminary and unaudited $304,545 in loan interest"

correct...$304,545 in INTEREST acc
KBLB
lovethatgreen lovethatgreen 1 hora hace
Thia account is suspended until Nov 2027
RITE
cptbac cptbac 1 hora hace
Exactly.
NWBO
janice shell janice shell 1 hora hace
By the way, I just watched that video. What on earth presumably makes you believe I think this country is okay, and going in the right direction?

I should have imagined that you'd understood from my many posts that I think we're headed to hell in a handbasket. Unlike you, I do not fe
StocktonCA StocktonCA 1 hora hace
this bill is on the current Congress' calender to be discussed sometime before the end of Feb

Shown Here:
Introduced in Senate (03/28/2023)

Setting Consumer Standards for Lithium-Ion Batteries Act

This bill requires the Consumer Product Safety Comm
TORVF
Chachang1 Chachang1 1 hora hace
It's nearly March. This stock has a history of running hard in March. First the float gets soaked up cheap which we have been seeing happening. Next, the Company will put out press and other media. Watch for this as they have been silent. Then boom, a run. As Florida stated he ran this from down her
RLTR
StocktonCA StocktonCA 1 hora hace
Shown Here:
Introduced in Senate (03/28/2023)

Setting Consumer Standards for Lithium-Ion Batteries Act

This bill requires the Consumer Product Safety Commission to issue a consumer product safety standard for rechargeable lithium-ion batteries used in micromobili
KULR

Su Consulta Reciente

Delayed Upgrade Clock